文献速递慢性肾脏病肾血管病与高血压血液净化与透析

CKD患者下肢并发症后肾衰竭、死亡及心血管事件风险

Risk of Kidney Failure, Death, and Cardiovascular Events After Lower Limb Complications in Patients With CKD.
PubMed 文献 · Kidney Int Rep · 2020-12-04

该回顾性队列研究基于加拿大曼尼托巴省行政数据库,纳入92618例CKD G3-G5期患者,中位随访2.56年。与未发生下肢并发症者相比,发生 interim 下肢并发症者肾衰竭风险(aHR 2.51,95%CI 2.10-3.00)、肾衰竭前全因死亡风险(aHR 2.73,95%CI 2.55-2.92)及心血管事件风险(aHR 2.12,95%CI 1.90-2.38)均显著升高。

要点

  • 下肢并发症与肾衰竭前全因死亡风险及心血管住院风险独立相关。
  • 对CKD患者进行下肢并发症筛查和治疗的临床试验可能有助于确定管理策略。

核心结论

  • CKD G3-G5期患者发生 interim 下肢并发症与随后肾衰竭、肾衰竭前全因死亡及心血管相关住院风险升高相关。

研究设计与样本

  • 回顾性队列研究,链接加拿大曼尼托巴省多个行政数据库获取患者层面数据,最终纳入92618例CKD G3-G5期患者,中位随访2.56年。
  • 采用Fine and Gray回归模型分析主要结局:肾衰竭(调整全因死亡的竞争风险)、肾衰竭前死亡、心血管相关住院(调整非心血管死亡的竞争风险)。

主要发现

  • 与未发生 interim 下肢并发症的患者相比,发生者肾衰竭风险升高(调整HR 2.51,95%CI 2.10-3.00)。
  • 发生下肢并发症者肾衰竭前全因死亡风险升高(调整HR 2.73,95%CI 2.55-2.92)。
  • 发生下肢并发症者心血管事件风险升高(调整HR 2.12,95%CI 1.90-2.38)。

临床怎么用

  • 临床上应关注CKD G3-G5期患者的下肢并发症,并将其视为肾衰竭、死亡及心血管事件的高危标志。
  • 对CKD患者开展下肢并发症筛查和治疗的临床试验可能有助于确定最佳风险管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Lower limb complications are major adverse events in patients with peripheral artery disease (PAD) and chronic kidney disease (CKD). These complications can lead to morbidity, disability, reduced quality of life, and higher health care costs. We sought to determine how interim lower limb complications modify the subsequent risk of progression to kidney failure, all-cause mortality before kidney failure, and cardiovascular (CV) events in a cohort of patients with CKD stages G3 to G5. METHODS: We performed a retrospective cohort study using patient-level data obtained by linking several administrative databases from Manitoba, Canada. We used Fine and Gray regression models for the primary outcomes of (1) kidney failure adjusted for the competing risk of all-cause mortality, (2) death before kidney failure, and (3) cardiovascular-related hospitalization with the competing risk of non-CV death. RESULTS: A total of 92,618 patients were included in the final cohort, with a median follow-up time of 2.56 years. Compared with patients who did not experience an interim lower limb complication, there was a higher risk of kidney failure (adjusted hazard ratio [HR] 2.51, 95% confidence interval [CI] 2.10-3.00), all-cause mortality before kidney failure (adjusted HR 2.73, 95% CI 2.55-2.92), and CV events (adjusted HR 2.12, 95% CI 1.90-2.38). CONCLUSIONS: Interim lower limb complications are associated with an increased risk of kidney failure, all-cause mortality before kidney failure, and cardiovascular-related hospitalization. Clinical trials of screening and treatment strategies for patients with CKD at risk for lower limb complications may help determine optimal strategies to manage this risk.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Li K, Ferguson T, Embil J, et al. Risk of Kidney Failure, Death, and Cardiovascular Events After Lower Limb Complications in Patients With CKD. Kidney Int Rep. 2020. PMID: 33615063. doi:10.1016/j.ekir.2020.11.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。